NCT02776046

Individualized Perioperative Open-lung Ventilatory Strategy With High Versus Conventional Inspiratory Oxygen Fraction (iPROVE-O2).

Individualized Perioperative Open-luna Ventilatory Strategy With High Versus Conventional Inspiratory Oxygen Fraction (iPROVE-O2). A Comparative, Prospective, Multicenter, Randomized Controlled Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 756 (estimated)
• Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The iPROVE-O2 trial aims at comparing the efficacy of high and conventional FiO2 within a perioperative individualized ventilatory strategy to reduce the overall incidence of SSI.

Conditions

• Hyperoxia
• Postoperative Complication
• Surgical Site Infection

Interventions

Type	Name	Description
DRUG	High FiO2	High FiO2 with a perioperative open lung strategy
DRUG	Conventional FiO2	Conventional FiO2 with a perioperative open lung strategy

Timeline

• Start date: 2017-06-01
• Primary completion: 2018-11-01
• Completion: 2019-02-01
• First posted: 2016-05-18
• Last updated: 2018-02-26

Locations

1 site across 1 country: Spain